Publications To Date

    nCOUNTER PUBLICATIONS

    Filter Publications

    PAGE 1 OF 7 | DISPLAYING 1 - 15 OF 95 RESULTS

    Parada H. et al., Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study, 10.1186/s13058-017-0914-6, Breast Can. Res., Dec 11, 2017

    Zapka P. et al., Type, Frequency, and Spatial Distribution of Immune Cell Infiltrates in CNS Germinomas: Evidence for Inflammatory and Immunosuppressive Mechanisms., 10.1093/jnen/nlx106, J. Neuropathol. Exp. Neurol., Dec 11, 2017

    Braun A. et al., Site-specific gene expression analysis from archived human intestine samples combining laser-capture microdissection and multiplexed color-coded probes., 10.1111/nmo.13261, Neurogastroenterol. Motil., Nov 28, 2017

    Lee J.Y. et al., Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract, 10.1016/j.tranon.2017.10.008, Trans. Oncol., Nov 21, 2017

    Boldrini L. et al., Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma, 10.1186/s12935-017-0474-y, Cancer Cell Int., Nov 17, 2017

    McRee A.J. et al., A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer, 10.1016/j.clbc.2017.10.014, Clin. Breast Can., Oct 14, 2017

    Low Y.S. et al., A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancer, https://doi.org/10.1016/j.canlet.2017.05.031, Cancer Letters, Sep 10, 2017

    Winham S.J. et al., NanoString-based breast cancer risk prediction for women with sclerosing adenosis., 10.1007/s10549-017-4441-z. [Epub ahead of print], Breast Cancer Res Treat. , Aug 10, 2017

    Evangelista A.F. et al., Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology, 2017 May 26. doi: 10.1186/s12890-017-0428-0, BMC. Pulm. Med., Aug 04, 2017

    Liu J.C. et al., Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERα- breast cancer, 2017 Jun 20. doi: 10.1371/journal.pone.0179223, PLoS ONE, Aug 04, 2017

    Patel P.G. et al., Reliability and performance of commercial RNA and DNA extraction kits for FFPE tissue cores, 2017 Jun 22. doi: 10.1371/journal.pone.0179732, PLoS ONE, Aug 04, 2017

    Toriola AT, et al. Increased breast tissue receptor activator of nuclear factor- κB ligand (RANKL) gene expression is associated with higher mammographic density in premenopausal women, DOI: 10.18632/oncotarget.17909, PubMed, Jun 20, 2017

    Pinto N, et al. Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors, doi: 10.1002/pbc.26613. [Epub ahead of print], Pediatr Blood Cancer, May 10, 2017

    Pinto J, et al. In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies, doi: 10.1038/s41598-017-01207-3, Sci Rep, May 08, 2017

    Yoo C., et al. Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma., 2017 Apr 7., Oncotarget, Apr 07, 2017